Company
Exact Sciences Corporation
Headquarters: Madison, WI, United States
Founded: 1995
Employees: 6,420
CEO: Mr. Kevin T. Conroy
Market Cap
$10.20 Billion
USD as of Jan. 1, 2025
Exact Sciences Corporation Categories
United States Healthcare Diagnostics & ResearchUnited States Healthcare United States Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | $2.69 B |
| EBITDA | $-11,337,000 |
| Gross Profit TTM | $1.96 B |
| Profit Margin | -7.95% |
| Operating Margin | -2.61% |
| Quarterly Revenue Growth | 12.80% |
Stocks & Indices
Exact Sciences Corporation has the following listings and related stock indices.
Stock: NASDAQ: EXAS wb_incandescent
Stock: FSX: EXK wb_incandescent
Product & Services
Cologuard
Key People
Founder(s): Stanley Lapidus, Anthony P. Shuber
Kevin Conroy (Chairman, President & CEO) Graham Lidgard (Chief Science Officer)